Jodi Eyigor is finding her distinct voice
Jodi Eyigor, Director of Nursing Home Quality and Policy, LeadingAge
Jodi Eyigor, Director of Nursing Home Quality and Policy, LeadingAge
Some look at the ongoing COVID-19 crisis and question how they can make their buildings safer. Eric Tanner, CEO of transitional and skilled care specialist OnPointe, sees the crisis as a launching point for irrevocable, industry-wide change.
Long-term care providers wary of extra scrutiny should also be prepared for new opportunities in an administration that will likely expand insurance coverage and embrace innovative care models that could reshape the referral process. That was one of several takeaways from Wednesday’s NIC Leadership huddle featuring post-acute care policy experts Dan Mendelson, founder of Avalere…
Despite more than 12,000 infection control-related citations given during the COVID-19 pandemic, most U.S. nursing homes didn’t see their ratings change much in updated Five-Star guidance published Wednesday. An analysis by Formation Healthcare Group found the prevalence of citations has not changed drastically during the pandemic, with the average health tags cited per facility dropping…
Survivors of a former North Carolina nursing home resident are suing the facility where she died in what could be a litmus test for the patchwork of liability protections granted to healthcare providers across the country. North Carolina is one of nearly 30 states that gave nursing homes legal immunity to shield them from lawsuits…
Fewer SNFs banked value-based incentives in pandemic-affected 2020 … Second monoclonal antibody formulation, this one with injectable option, shows promise as COVID-19 preventative … Police: Nursing home employee exploited electronic system to order Oxy refills — for herself … Johnson & Johnson says it can produce up to 100 million single-dose coronavirus vaccines by June…
Early this month, AMFM Nursing & Rehabilitation Centers celebrated the completion of second-round COVID-19 vaccinations at all 19 of its buildings — before many had even offered a first round and nearly two months ahead of the target a national provider organization has set for all U.S. facilities to finish both rounds.
COVID-19 monoclonal antibodies are now widely available for use by skilled nursing facilities — and early results show promise, according to long-term care pharmacy leaders.
Even as the U.S. government authorized Pfizer’s coronavirus vaccine for emergency use late last week, drugmakers around the world acknowledged new challenges in developing other immunizing drugs that would bolster supplies.